The mRNA-based vaccines that turned the tide of the COVID-19 pandemic currently account for almost all the value of the mRNA vaccine/therapeutic market. Indeed, the vaccine-led response to the ...
SEOUL, South Korea--(BUSINESS WIRE)--Lemonex Inc., a biotechnology company developing innovative messenger RNA (mRNA) and siRNA therapeutics based on a novel nanoparticle drug delivery system ...
Innovation Center of NanoMedicine (Center Director: Prof. Kazunori Kataoka) has announced that Prof. Satoshi Uchida (Principal Research Scientist), who is also Associated Professor of the Kyoto ...
Ottawa, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The global mRNA quality monitoring market size is calculated at USD 1.37 billion in 2025 and is expected to reach around USD 2.5 billion by 2034, growing at a ...
CAMBRIDGE, Mass., August 28, 2025 – Raina Biosciences Inc., (“Raina”), an mRNA technology and therapeutics company, today announced the publication of data from its generative AI platform in Science.
Moderna Inc (NASDAQ:MRNA) provided an update on regulatory submissions for the mRNA-1345 vaccine to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease in ...
Messenger RNA, or mRNA, plays a fundamental role in human biology, transferring the instructions stored in DNA to create the proteins required in every living cell. Therefore, given the right approach ...
STONY BROOK, NY / ACCESSWIRE / August 23, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the filing with the ...
YONGIN, South Korea, Sept. 22, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading South Korean pharmaceutical company, announced today that it has submitted an Investigational New Drug (IND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback